Biosimilars are inexpensive imitation drugs of expensive biological drugs. Now, Swissmedic has confirmed that the two types of drugs are comparable in terms of efficacy and safety. The Federal Office of Public Health (FOPH) therefore intends to promote the dispensing of biosimilars in the course of ongoing revision projects.
This content is machine-translated. Please contact us if you need professional translation services.
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
